DK0984982T3 - LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem - Google Patents

LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem

Info

Publication number
DK0984982T3
DK0984982T3 DK98924306T DK98924306T DK0984982T3 DK 0984982 T3 DK0984982 T3 DK 0984982T3 DK 98924306 T DK98924306 T DK 98924306T DK 98924306 T DK98924306 T DK 98924306T DK 0984982 T3 DK0984982 T3 DK 0984982T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
compositions containing
peptide analogues
analogues
peptide
Prior art date
Application number
DK98924306T
Other languages
English (en)
Inventor
Remi Delansorne
Jacques Paris
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Application granted granted Critical
Publication of DK0984982T3 publication Critical patent/DK0984982T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DK98924306T 1997-06-02 1998-05-06 LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem DK0984982T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97401212A EP0882736A1 (en) 1997-06-02 1997-06-02 LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
PCT/EP1998/002802 WO1998055505A1 (en) 1997-06-02 1998-05-06 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK0984982T3 true DK0984982T3 (da) 2001-11-12

Family

ID=8229769

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924306T DK0984982T3 (da) 1997-06-02 1998-05-06 LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem

Country Status (38)

Country Link
US (1) US6586402B1 (da)
EP (2) EP0882736A1 (da)
JP (1) JP4346115B2 (da)
KR (1) KR100582510B1 (da)
CN (1) CN1134450C (da)
AP (1) AP1195A (da)
AR (1) AR011734A1 (da)
AT (1) ATE204297T1 (da)
AU (1) AU746132B2 (da)
BR (1) BR9809910A (da)
CA (1) CA2292846C (da)
CO (1) CO4790174A1 (da)
CZ (1) CZ299308B6 (da)
DE (1) DE69801369T2 (da)
DK (1) DK0984982T3 (da)
DZ (1) DZ2509A1 (da)
EE (1) EE03879B1 (da)
ES (1) ES2166166T3 (da)
HK (1) HK1029124A1 (da)
HU (1) HUP0003592A3 (da)
ID (1) ID24520A (da)
IL (1) IL133210A0 (da)
JO (1) JO2034B1 (da)
MA (1) MA26502A1 (da)
MY (1) MY122262A (da)
NO (1) NO321786B1 (da)
NZ (1) NZ501463A (da)
OA (1) OA11305A (da)
PE (1) PE84999A1 (da)
PL (1) PL195474B1 (da)
PT (1) PT984982E (da)
RU (1) RU2212247C2 (da)
SI (1) SI0984982T1 (da)
TN (1) TNSN98075A1 (da)
TR (1) TR199902997T2 (da)
TW (1) TW479062B (da)
WO (1) WO1998055505A1 (da)
ZA (1) ZA983992B (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
US20020071829A1 (en) * 1999-04-15 2002-06-13 Richard Boyd Normalization of defective T cell responsiveness through manipulation of thymic regeneration
AU2524502A (en) * 2000-10-13 2002-04-22 Richard Boyd Improvement of graft acceptance through manipulation of thymic regeneration
GB0307777D0 (en) 2003-04-04 2003-05-07 Medical Res Council Conjugate compounds
DE102004033902A1 (de) * 2004-07-14 2006-02-16 Zentaris Gmbh Neue Tetrahydrocarbazolderivate mit verbesserter biologischer Wirkung und verbesserter Löslichkeit als Liganden für G-Protein gekoppelte Rezeptoren (GPCR's)
JP2009519942A (ja) 2005-12-14 2009-05-21 アンブルックス，インコーポレイテッド 非天然アミノ酸およびポリペプチドを含んでいる組成物、それらに関する方法、ならびに、それらの使用
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN110133296B (zh) * 2012-03-18 2022-03-25 镜株式会社 疾病样品分析装置、分析系统及分析方法
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9393264B2 (en) * 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途
CN114014913B (zh) * 2022-01-10 2022-03-29 浙江湃肽生物有限公司南京分公司 醋酸曲普瑞林的纯化方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO139560C (no) * 1972-04-29 1979-04-04 Takeda Chemical Industries Ltd Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
DE2424287A1 (de) * 1974-05-18 1975-12-04 Hoechst Ag Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
US4565804A (en) * 1984-09-07 1986-01-21 The Salk Institute For Biological Studies GnRH Antagonists VI
US5003011A (en) * 1985-04-09 1991-03-26 The Administrators Of The Tulane Educational Fund Therapeutic decapeptides
US4935491A (en) * 1987-08-24 1990-06-19 Board Of Regents, The University Of Texas System Effective antagonists of the luteinizing hormone releasing hormone which release negligible histamine
EP0328090A3 (en) * 1988-02-10 1990-08-16 Abbott Laboratories Lhrh analogs
US5110904A (en) * 1989-08-07 1992-05-05 Abbott Laboratories Lhrh analogs
US5140009A (en) * 1988-02-10 1992-08-18 Tap Pharmaceuticals, Inc. Octapeptide LHRH antagonists
EP0842946A1 (en) * 1996-11-14 1998-05-20 Laboratoire Theramex S.A. Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
EP0882736A1 (en) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. LH-RH peptide analogues, their uses and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
HK1029124A1 (en) 2001-03-23
US6586402B1 (en) 2003-07-01
AR011734A1 (es) 2000-08-30
EP0882736A1 (en) 1998-12-09
RU2212247C2 (ru) 2003-09-20
AP9901702A0 (en) 1999-12-31
HUP0003592A2 (hu) 2001-02-28
KR100582510B1 (ko) 2006-05-23
CA2292846C (en) 2009-12-08
DZ2509A1 (fr) 2003-01-25
OA11305A (en) 2003-08-25
NO995891L (no) 2000-02-01
DE69801369T2 (de) 2002-05-16
EE03879B1 (et) 2002-10-15
MY122262A (en) 2006-04-29
CZ432999A3 (cs) 2000-06-14
CN1134450C (zh) 2004-01-14
NO995891D0 (no) 1999-12-01
DE69801369D1 (de) 2001-09-20
AP1195A (en) 2003-08-18
BR9809910A (pt) 2000-08-01
ID24520A (id) 2000-07-20
WO1998055505A1 (en) 1998-12-10
AU746132B2 (en) 2002-04-18
AU7654198A (en) 1998-12-21
NO321786B1 (no) 2006-07-03
SI0984982T1 (en) 2002-02-28
ATE204297T1 (de) 2001-09-15
CO4790174A1 (es) 1999-05-31
PL337235A1 (en) 2000-08-14
ZA983992B (en) 1998-11-20
EE9900546A (et) 2000-06-15
CN1263535A (zh) 2000-08-16
MA26502A1 (fr) 2004-12-20
EP0984982B1 (en) 2001-08-16
NZ501463A (en) 2001-07-27
CA2292846A1 (en) 1998-12-10
HUP0003592A3 (en) 2001-05-28
JP2002502396A (ja) 2002-01-22
IL133210A0 (en) 2001-03-19
ES2166166T3 (es) 2002-04-01
KR20010013286A (ko) 2001-02-26
JO2034B1 (en) 1999-05-15
PT984982E (pt) 2002-02-28
TR199902997T2 (xx) 2000-03-21
CZ299308B6 (cs) 2008-06-11
TNSN98075A1 (fr) 2005-03-15
PL195474B1 (pl) 2007-09-28
JP4346115B2 (ja) 2009-10-21
TW479062B (en) 2002-03-11
EP0984982A1 (en) 2000-03-15
PE84999A1 (es) 1999-09-15

Similar Documents

Publication Publication Date Title
DK0984982T3 (da) LH-RH-peptidanaloger, anvendelse deraf og farmaceutiske præparater indeholdende dem
HUP0100100A3 (en) Hepatitis c inhibitor peptide analogues, pharmaceutical compositions comprising thereof and their use
NO308298B1 (no) Substituerte kinazolinderivater, anvendelse derav og farmasøytiske preparater inneholdende dem
ITRM960810A0 (it) Composizioni farmaceutiche contenenti ciclosporine o macrolidi
HUP0003349A3 (en) Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use
HUP0103265A2 (hu) Proszapozineredetű ciklikus peptidek, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
NO942835L (no) 1-benzensulfonyl-1,3-dihydro-2H-benzimidazol-2-on-derivater, fremstilling derav og farmasöytiske blandinger som inneholder dem
DK1112266T3 (da) Substituerede 4-amino-2-arylpyrimidiner, fremstilling og anvendelse deraf og farmaceutiske præparater indeholdende dem
EE03664B1 (et) Farmatseutilised aerosoolkompositsioonid
HUP0104934A3 (en) Peptide analogues of pacap, pharmaceutical compositions comprising thereof and their use
NO976128L (no) Forbindelser og farmasöytiske blandinger som inneholder dem
HUP0000762A3 (en) 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them
HUP0002272A3 (en) Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use
HRP950612B1 (en) PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM
HUP0004561A3 (en) Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof
HUP9802132A3 (en) Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them
HUP0001940A3 (en) Benzisothiazole derivatives, their use and pharmaceutical compositions containing them
DK1005342T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
NO975365L (no) Benzopyraner og farmasöytiske sammensetninger inneholdende dem
HUP9802590A3 (en) Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them
ZA9710254B (en) LH-RH peptide analogues, their uses and pharmaceutical composition containing them.
HUP9903500A3 (en) Thiophene-, furane- and pyrrolesulfonamides, their use and pharmaceutical compositions containing them
DK0979244T3 (da) Cyclosporinderivater, deres fremstilling og farmaceutiske præparater, der indeholder dem
IL123995A (en) Peptide derivatives, their preparation and pharmaceutical compositions comprising them
HUP9701051A3 (en) Pharmaceutical compositions containing natural active components